Conservative versus surgical management of placenta accreta spectrum following mid-trimester abortion: a case series

Authors

  • Archita Srivastava Department of Obstetrics and Gynecology, Rama Medical College, Kanpur, Uttar Pradesh, India

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20263051

Keywords:

Placenta accreta spectrum, Placenta increta, Mid-trimester abortion, Methotrexate, Hysterectomy, Retained products of conception

Abstract

Placenta accreta spectrum (PAS) is a rare but potentially life-threatening obstetric condition characterized by abnormal placental adherence or invasion into the myometrium. Although it is commonly associated with previous cesarean delivery, PAS may rarely occur following spontaneous mid-trimester abortion in women without a uterine scar. We present two cases of placenta increta diagnosed after spontaneous mid-trimester abortion with retained products of conception and persistent vaginal bleeding. Both patients underwent transvaginal ultrasonography with colour Doppler followed by pelvic magnetic resonance imaging (MRI), which confirmed focal myometrial invasion. The first patient, a 31-year-old multiparous woman who desired future fertility, was managed conservatively with systemic methotrexate, serial serum beta-human chorionic gonadotropin (β-hCG) monitoring, and close ultrasonographic follow-up, resulting in complete resolution of retained placental tissue. The second patient, a 43-year-old multiparous woman with completed family and severe anemia underwent total laparoscopic hysterectomy with bilateral salpingo-oophorectomy after preoperative optimization with blood transfusion and had an uneventful postoperative recovery. These cases highlight that PAS should be considered in women presenting with persistent bleeding after spontaneous abortion, particularly when highly vascular retained products are identified on imaging. Early diagnosis using ultrasonography and MRI facilitates timely individualized management. Conservative treatment may be successful in carefully selected women desiring fertility preservation, whereas hysterectomy remains the definitive treatment in women with completed family or significant risk of hemorrhage.

References

Silver RM, Branch DW. Placenta accreta spectrum. N Engl J Med. 2018;378:1529-36.

Jauniaux E, Chantraine F, Silver RM, Langhoff-Roos J. FIGO consensus guidelines on placenta accreta spectrum disorders: epidemiology and risk factors. Int J Gynaecol Obstet. 2018;140(3):265-73.

Collins SL, Ashcroft A, Braun T, Calda P, Langhoff-Roos J, Morel O. Proposal for standardized ultrasound descriptors of placenta accreta spectrum disorders. Ultrasound Obstet Gynecol. 2016;47(3):271-5.

D'Antonio F, Iacovella C, Bhide A. Prenatal identification of invasive placentation using magnetic resonance imaging: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2014;44(1):8-16.

Sentilhes L, Kayem G, Chandraharan E, Palacios-Jaraquemada J, Jauniaux E. FIGO consensus guidelines on placenta accreta spectrum disorders: conservative management. Int J Gynaecol Obstet. 2018;140(3):291-8.

Eller AG, Porter TF, Soisson P, Silver RM. Optimal management strategies for placenta accreta. BJOG. 2009;116(5):648-54.

Belfort MA. Placenta accreta. Am J Obstet Gynecol. 2010;203(5):430-9.

Jauniaux E, Bhide A. Prenatal ultrasound diagnosis and outcome of placenta previa accreta after cesarean delivery: systematic review and meta-analysis. Am J Obstet Gynecol. 2017;217(1):27-36.

Downloads

Published

2026-08-27

How to Cite

Srivastava, A. (2026). Conservative versus surgical management of placenta accreta spectrum following mid-trimester abortion: a case series. International Journal of Reproduction, Contraception, Obstetrics and Gynecology, 15(9), 3640–3644. https://doi.org/10.18203/2320-1770.ijrcog20263051

Issue

Section

Case Series